Skip to main content
. 2019 Oct 17;10:301. doi: 10.1186/s13287-019-1405-8

Fig. 3.

Fig. 3

MSCs obtained by MEC meet the criteria of MSCs proposed by the ISCT. a Cell surface markers of MSCs (N = 3, P3) were analyzed by flow cytometry. All MSCs were positive for CD105, CD90, CD73, CD44, and CD166 (≥ 95%) and negative for CD14, CD34, CD19, CD45, and HLA-DR (≤ 2%). b Trilineage differentiation of all MSCs (P3)